۱. FALAHZADEH M, FALAHZADEH M, SHAHRIARI M, RASTGAR S, Derakhshan A, FALAHZADEH M. Hematuria in patients with Beta-thalassemia major. ۲۰۱۰.

 

 

۲. Fallahzadeh M, Fallahzadeh M, Mowla A, Derakhshan A. Hypercalciuria in children with urinary tract symptoms. Saudi Journal of Kidney Diseases and Transplantation. ۲۰۱۰;۲۱(۴).

 

 

۳. Hosseini M, Aminsharifi A, Ariafar A, Tadayyon A, Ahmad E, Manaheji F, et al. S۱۸۷ percutaneouS nephrolithotomy (pcnl) with one-Shot metalic cone-tip dilator. European Urology Supplements. ۲۰۱۰;۹(۶).

 

 

۴. Hosseini M, Aminsharifi A, Mostafavi M. S۱۸۸ Radiation-free percutaneous nephrolithotomy (PCNL) in pregnancy. European Urology Supplements. ۲۰۱۰;۹(۶).

 

 

۵. Hosseini MM, Eshraghian A, Dehghanian I, Irani D, Amini M. Metabolic abnormalities in patients with nephrolithiasis: comparison of first-episode with recurrent cases in Southern Iran. International urology and nephrology. ۲۰۱۰;۴۲(۱):۱۲۷-۳۱.

 

 

۶. Jalali GR, Roozbeh J, Mohammadzadeh A, Sharifian M, Sagheb MM, Jahromi AH, et al. Impact of oral zinc therapy on the level of sex hormones in male patients on hemodialysis. Renal failure. ۲۰۱۰;۳۲(۴):۴۱۷-۹.

 

 

۷. Janati M, Mahmoodi Y, Sharifian M, Amooee S, Kojuri J, Hekmati P, et al. Prevalence and risk factors of acute renal failure after cardiac surgery in Southern Iran. ۲۰۱۰.

 

 

۸. Karami H, Mohammad HM, Rezaei A, Mazloomfard M. S۱۹۱ BLIND VERSUS FLUOROSCOPY-GUIDED PERCUTANEOUS NEPHROLITHOTOMY: A RANDOMIZED CLINICAL TRIAL. European Urology Supplements. ۲۰۱۰;۹(۶):۶۰۴-۵.

 

 

۹. MALEK ML, Haghpanah S, Pakfetrat M, MALEKMAKAN A, ALIMANESH M, HAGHPANAH A, et al. Dialysis adequacy and Kidney Disease Outcomes Quality Initiative goals achievement in an Iranian hemodialysis population. ۲۰۱۰.

 

 

۱۰. Pakfetrat M, Malekmakan L, Hasheminasab M. Diminished selenium levels in hemodialysis and continuous ambulatory peritoneal dialysis patients. Biological trace element research. ۲۰۱۰;۱۳۷(۳):۳۳۵-۹.

 

 

۱۱. Pakfetrat M, Nikoo MH, Malekmakan L, Tabande M, Roozbeh J, GANBAR ALI RJ, et al. Comparison of risk factors for contrast‐induced acute kidney injury between patients with and without diabetes. Hemodialysis International. ۲۰۱۰;۱۴(۴):۳۸۷-۹۲.

 

 

۱۲. Pakfetrat M, NIKOU M, MALEK ML, TABANDEH M, ROUZBEH J, RAEIS JGA, et al. Risk Factors for contrast-related acute kidney injury according to risk, injury, failure, loss, and end-stage criteria in patients with coronary interventions. ۲۰۱۰.

 

 

۱۳. Pakfetrat M, Roozbeh J, Malekmakan L, Zare N, Nasab MH, Nikoo MH. Relation of serum albumin and C-reactive protein to hypotensive episodes during hemodialysis sessions. Saudi Journal of Kidney Diseases and Transplantation. ۲۰۱۰;۲۱(۴).

 

 

۱۴. Pakfetrat M, ROOZBEH SHAHROODI J, Malekmakan L, Zare N, Nasab MH, HOSSEIN NIKOO M. Is there an association between intradialytic hypotension and serum magnesium changes? Hemodialysis International. ۲۰۱۰;۱۴(۴):۴۹۲-۷.

 

 

۱۵. Roozbeh J, Banihashemi MA, Ghezlou M, Afshariani R, Salari S, Moini M, et al. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy. Renal failure. ۲۰۱۰;۳۲(۲):۱۷۲-۸.